FI950397L - Polyatsamakrosyklisiä yhdisteitä metalli-ionien kompleksointia varten - Google Patents

Polyatsamakrosyklisiä yhdisteitä metalli-ionien kompleksointia varten Download PDF

Info

Publication number
FI950397L
FI950397L FI950397A FI950397A FI950397L FI 950397 L FI950397 L FI 950397L FI 950397 A FI950397 A FI 950397A FI 950397 A FI950397 A FI 950397A FI 950397 L FI950397 L FI 950397L
Authority
FI
Finland
Prior art keywords
complexation
metal ions
polyazamacrocyclic compounds
polyazamacrocyclic
compounds
Prior art date
Application number
FI950397A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI950397A0 (fi
FI950397A7 (fi
Inventor
Allan Dean Sherry
Garry E Kiefer
Original Assignee
Univ Texas
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/662,075 external-priority patent/US4639365A/en
Application filed by Univ Texas, Dow Chemical Co filed Critical Univ Texas
Publication of FI950397A0 publication Critical patent/FI950397A0/fi
Publication of FI950397L publication Critical patent/FI950397L/fi
Publication of FI950397A7 publication Critical patent/FI950397A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
FI950397A 1984-10-18 1993-06-28 Polyatsamakrosyklisiä yhdisteitä metalli-ionien kompleksointia varten FI950397A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/662,075 US4639365A (en) 1984-10-18 1984-10-18 Gadolinium chelates as NMR contrast agents
US07/923,715 US5362476A (en) 1984-10-18 1992-07-31 Alkyl phosphonate polyazamacrocyclic cheates for MRI
PCT/US1993/006158 WO1994003464A1 (en) 1984-10-18 1993-06-28 Polyazamacrocyclic compounds for complexation of metal ions

Publications (3)

Publication Number Publication Date
FI950397A0 FI950397A0 (fi) 1995-01-30
FI950397L true FI950397L (fi) 1995-01-30
FI950397A7 FI950397A7 (fi) 1995-01-30

Family

ID=34922820

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950397A FI950397A7 (fi) 1984-10-18 1993-06-28 Polyatsamakrosyklisiä yhdisteitä metalli-ionien kompleksointia varten

Country Status (19)

Country Link
US (2) US5362476A (es)
EP (2) EP0652885B1 (es)
JP (1) JP3411919B2 (es)
CN (1) CN1040750C (es)
AT (2) ATE169827T1 (es)
AU (1) AU4654893A (es)
CA (1) CA2140557A1 (es)
DE (2) DE69331203T2 (es)
DK (1) DK0855401T3 (es)
ES (1) ES2167667T3 (es)
FI (1) FI950397A7 (es)
HU (1) HUT70447A (es)
IL (1) IL106164A0 (es)
MX (1) MX9304624A (es)
NO (1) NO306466B1 (es)
PH (1) PH30934A (es)
PT (1) PT855401E (es)
WO (1) WO1994003464A1 (es)
ZA (1) ZA935541B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714604A (en) * 1993-05-06 1998-02-03 The Dow Chemical Company Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives
US7186688B1 (en) 1994-03-08 2007-03-06 Human Genome Sciences, Inc. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
EP0841951A2 (en) * 1995-06-26 1998-05-20 Concat Ltd. Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
US5952732A (en) * 1997-11-10 1999-09-14 Scarpitti; Ernest A Vehicle security system
EP1362861B1 (en) * 1999-09-13 2005-12-14 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
US6685914B1 (en) 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
DE60006587T2 (de) * 1999-09-13 2004-09-16 Bristol-Myers Squibb Pharma Co. Makrozyclische liganden für metallpharmazeutika
US6565828B2 (en) 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
DE60137335D1 (de) * 2000-08-07 2009-02-26 Univ Vanderbilt Nachweis der COX-2 Aktivität und von Anandamid-Metaboliten
US7048907B2 (en) * 2001-02-05 2006-05-23 Biophysics Assay Laboratory, Inc. Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products
AU2002323528C1 (en) * 2001-09-04 2009-11-12 Texas Tech University Multi-use multimodal imaging chelates
US20030133872A1 (en) * 2001-10-22 2003-07-17 Kiefer Garry E. Radiopharmaceutical agent for the treatment of early stage cancer
WO2003067286A2 (en) * 2002-02-07 2003-08-14 Covalent Partners, Llc Nanofilm and membrane compositions
US20040034223A1 (en) * 2002-02-07 2004-02-19 Covalent Partners, Llc. Amphiphilic molecular modules and constructs based thereon
US20040106741A1 (en) * 2002-09-17 2004-06-03 Kriesel Joshua W. Nanofilm compositions with polymeric components
EP1778699A4 (en) * 2004-08-10 2009-02-25 Dow Global Technologies Inc TARGETING OF CHELANTS AND CHELATES
JP5345945B2 (ja) 2006-12-11 2013-11-20 ブラッコ・イメージング・ソシエタ・ペル・アチオニ フィブリン結合ペプチドおよびそのコンジュゲート
EP2476703A1 (en) 2011-01-14 2012-07-18 Bracco Imaging S.p.A Human antibodies cross-reacting with a bacterial and a self antigen from atherosclerotic plaques
US7595699B1 (en) * 2008-03-04 2009-09-29 Freescale Semiconductor, Inc. Look loop circuit and method having improved lock time
EP2147684A1 (en) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Diagnostic Agents Selective Against Metalloproteases
BR112013000236B1 (pt) * 2010-07-06 2018-11-13 Catexel Limited método de produzir um composto, e, sal protonado
WO2012095516A1 (en) 2011-01-14 2012-07-19 Bracco Imaging Spa Human antibodies cross-reacting with a bacterial and a self antigen from atherosclerotic plaques
CA3011248A1 (en) 2016-02-09 2017-08-17 Bracco Suisse Sa A recombinant chimeric protein for selectins targeting

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932451A (en) * 1973-11-27 1976-01-13 E. I. Du Pont De Nemours & Company 1,4,7,10-Tetraazatetracyclo[5.5.1.04,13.010,13 ]tridecane and its conjugate acids
US3930867A (en) * 1974-01-07 1976-01-06 E. I. Du Pont De Nemours And Company Macrocyclic polyamines as sensitizers for silver halide emulsions
US4038312A (en) * 1975-08-22 1977-07-26 E. I. Du Pont De Nemours And Company Tricyclic phosphorous triamides
US3996276A (en) * 1975-08-22 1976-12-07 E. I. Du Pont De Nemours And Company Bicyclic and tricyclic phosphorous triamides
US3987128A (en) * 1975-08-22 1976-10-19 E. I. Du Pont De Nemours And Company Tetracyclic tetraamino phosphoranes and method of preparation
US4085106A (en) * 1976-01-07 1978-04-18 E. I. Du Pont De Nemours And Company Bicyclic and tricyclic trisaminomethanes
DE2740170C2 (de) * 1977-05-17 1982-02-04 Tabushi, Iwao, Kyoto Alkylsubstituierte cyclische Tetraalkylentetramine
US4337154A (en) * 1979-04-04 1982-06-29 Nippon Shokubai Kagaku Kogyo Co., Ltd. Crosslinked composite semipermeable membrane
US4432907A (en) * 1979-09-10 1984-02-21 Analytical Radiation Corporation Diamine acid fluorescent chelates
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4421671A (en) * 1982-06-18 1983-12-20 General Electric Company Rare-earth-doped yttria-gadolinia ceramic scintillators
SU1081169A1 (ru) * 1982-12-13 1984-03-23 Ордена Ленина институт элементоорганических соединений им.А.Н.Несмеянова @ , @ , @ -Трис(диоксифосфорилметил)-1,4,7-триазациклононан в качестве комплексона дл селективного св зывани катионов магни ,цинка,меди,никел
US4731239A (en) * 1983-01-10 1988-03-15 Gordon Robert T Method for enhancing NMR imaging; and diagnostic use
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
US4775522A (en) * 1983-03-04 1988-10-04 Children's Hospital Research Foundation, A Division Of Children's Hospital Medical Center NMR compositions for indirectly detecting a dissolved gas in an animal
CA1317937C (en) * 1984-10-18 1993-05-18 A. Dean Sherry Gadolinium chelates with carboxymethyl derivatives of polyazamacrocycles as nmr contrast agents
US5342606A (en) * 1984-10-18 1994-08-30 Board Of Regents, The University Of Texas System Polyazamacrocyclic compounds for complexation of metal ions
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
EP0232751B1 (en) * 1986-01-23 1991-09-11 E.R. Squibb & Sons, Inc. 1-substituted-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
FR2614020B1 (fr) * 1987-04-14 1989-07-28 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
US4889931A (en) * 1988-09-27 1989-12-26 Salutar, Inc. Manganese (II) chelate manufacture
BR8907277A (pt) * 1988-12-22 1991-03-26 Dow Chemical Co Processo para preparar poliazamacrociclos mono-n-alquilados
GB8903023D0 (en) * 1989-02-10 1989-03-30 Parker David Chemical compounds
GB8914543D0 (en) * 1989-06-23 1989-08-09 Parker David Chemical compounds
US5236695A (en) * 1989-11-27 1993-08-17 Concat, Ltd. MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
CN1040750C (zh) 1998-11-18
EP0855401A1 (en) 1998-07-29
NO950346D0 (no) 1995-01-30
ATE169827T1 (de) 1998-09-15
DE69331203T2 (de) 2002-05-08
NO306466B1 (no) 1999-11-08
ATE209211T1 (de) 2001-12-15
US5362476A (en) 1994-11-08
EP0652885B1 (en) 1998-08-19
FI950397A0 (fi) 1995-01-30
CN1084514A (zh) 1994-03-30
DE69331203D1 (de) 2002-01-03
EP0855401B1 (en) 2001-11-21
DE69320481D1 (de) 1998-09-24
DE69320481T2 (de) 1999-03-18
IL106164A0 (en) 1993-10-20
PH30934A (en) 1997-12-23
ZA935541B (en) 1994-02-24
EP0652885A1 (en) 1995-05-17
HUT70447A (en) 1995-10-30
CA2140557A1 (en) 1994-02-17
US5630997A (en) 1997-05-20
ES2167667T3 (es) 2002-05-16
JP3411919B2 (ja) 2003-06-03
HU9500283D0 (en) 1995-03-28
NO950346L (no) 1995-01-30
JPH08500346A (ja) 1996-01-16
AU4654893A (en) 1994-03-03
MX9304624A (es) 1994-08-31
WO1994003464A1 (en) 1994-02-17
DK0855401T3 (da) 2002-05-21
FI950397A7 (fi) 1995-01-30
PT855401E (pt) 2002-04-29

Similar Documents

Publication Publication Date Title
FI950397L (fi) Polyatsamakrosyklisiä yhdisteitä metalli-ionien kompleksointia varten
GB8501889D0 (en) Heterocyclic compounds
EP0182054A3 (en) Heterocyclic compounds
EG17800A (en) Heterocyclic compounds
EP0290041A3 (en) Radioactive metal chelates of dipyridoxyl phosphate
GB8412750D0 (en) Heterocyclic compounds
PL252743A1 (en) Method of obtaining heterocyclic compounds
DK472085A (da) Metalcomplexer af bis-indolforbindelser
EP0181145A3 (en) Heterocyclic compounds
GB8410989D0 (en) Heterocyclic compounds
GB8421039D0 (en) Heterocyclic compounds
GB8425969D0 (en) Heterocyclic compounds
FI932231A7 (fi) Polyatsamakrosykliset yhdisteet metalli-ionien kompleksointiin
ZA85619B (en) Heterocyclic compounds
JPS57171976A (en) Manufacture of heterocyclic compounds
GB8429128D0 (en) Heterocyclic compounds
GB8412181D0 (en) Heterocyclic compounds
GB8429127D0 (en) Heterocyclic compounds
GB8414202D0 (en) Heterocyclic compounds
GB8414787D0 (en) Heterocyclic compounds
GB8420355D0 (en) Heterocyclic compounds
GB8405986D0 (en) Heterocyclic compounds
GB8404701D0 (en) Heterocyclic compounds
GB8425959D0 (en) Heterocyclic compounds
GB8402348D0 (en) Heterocyclic compounds